Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database

被引:0
|
作者
Chen, Jinhua [1 ,2 ]
Yu, Weijiang [1 ,2 ]
Zhang, Wancun [3 ]
Sun, Cuicui [4 ]
Zhang, Wenzhou [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Pharm, Zhengzhou, Peoples R China
[2] Henan Canc Hosp, Henan Engn Res Ctr Tumor Precis Med & Comprehens E, Henan Prov Key Lab Anticanc Drug Res, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Childrens Hosp, Dept Pediat Oncol Surg, Hlth Commiss,Henan Prov Key Lab Precis Diag & Trea, Zhengzhou, Peoples R China
[4] Shandong Univ, Qilu Hosp, Dept Pharm, Jinan, Peoples R China
关键词
Pseudomembranous colitis; antibiotic; FAERS; adverse event; disproportionality analyzes; CLOSTRIDIUM-DIFFICILE INFECTION; EPIDEMIOLOGY; DIARRHEA;
D O I
10.1080/14740338.2024.2341813
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundEvaluating antibiotics most commonly associated with pseudomembranous colitis (PMC) based on the real-world data is of great significance.Research design and methodsWe used the data from FAERS to evaluate the potential association between antibiotics and PMC by disproportionality analyzes.ResultsEighty-one antibiotics which met the three algorithms simultaneously were enrolled. There were 1683 reports of PMC associated with the enrolled antibiotics. In the top 24 antibiotics, cefoxitin, streptomycin, fosfomycin, and micafungin had a high risk of PMC, but there were few reports in the literature.ConclusionsThis study was of great significance for healthcare professionals to realize the potential PMC risks of antibiotics.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Subeesh, Viswam
    Maheswari, Eswaran
    Singh, Hemendra
    Beulah, Thomas Elsa
    Swaroop, Ann Mary
    [J]. CURRENT DRUG SAFETY, 2019, 14 (01) : 21 - 26
  • [2] Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Gu, Joyce H.
    Sheingold, Zachary
    Samarneh, Mark
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [3] Hypnotics and infections: disproportionality analysis of the US Food & Drug Administration adverse event reporting system database
    Meng, Long
    Huang, Jing
    He, Qin
    Zhao, Yibei
    Zhao, Wenlong
    Tan, Juntao
    Sun, Shusen
    Yang, Junqing
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (09): : 2229 - 2235
  • [4] Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
    Christodoulos, Iole N.
    Chyou, Te-yuan
    Nishtala, Prasad S.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (12) : 1775 - 1776
  • [5] Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
    Iole N. Christodoulos
    Te-yuan Chyou
    Prasad S. Nishtala
    [J]. European Journal of Clinical Pharmacology, 2020, 76 : 1775 - 1776
  • [6] Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Tanni, Kaniz Afroz
    Truong, Cong Bang
    Almahasis, Sura
    Qian, Jingjing
    [J]. BIODRUGS, 2021, 35 (02) : 239 - 254
  • [7] Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Kaniz Afroz Tanni
    Cong Bang Truong
    Sura Almahasis
    Jingjing Qian
    [J]. BioDrugs, 2021, 35 : 239 - 254
  • [8] Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database
    Xue, Xiangzhong
    Qian, Jingjing
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [9] Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
    Putzke, Joerg
    Haughie, Scott
    Zou, Kelly H.
    Ranganna, Gopinath M.
    [J]. BIODRUGS, 2021, 35 (03) : 373 - 374
  • [10] A pharmacovigilance study of adverse events associated with polymyxins based on the US Food and Drug Administration Adverse Event Reporting System (FAERS) database
    Wu, Tingxi
    Shi, Yanfeng
    Xu, Chang
    Zhu, Bin
    Li, Dandan
    Li, Zhe
    Zhao, Zhigang
    Zhang, Yang
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,